Personalized RNA Vaccine Advances for 2 Deadly Cancers, Targeting TNBC and Pancreatic Tumors
Updated
Updated · Oncodaily · Aug 15
Personalized RNA Vaccine Advances for 2 Deadly Cancers, Targeting TNBC and Pancreatic Tumors
1 articles · Updated · Oncodaily · Aug 15
Summary
Houston Methodist oncologist Maen Abdelrahim said a personalized RNA vaccine for triple-negative breast cancer and pancreatic cancer is moving through the pipeline after a presentation by RNA-vaccine expert John Cooke.
2 hard-to-treat cancers are the focus of the candidate, which Abdelrahim described as very promising for patients facing especially devastating disease.
LinkedIn remarks from Abdelrahim offered no trial data, timeline or regulatory details, leaving the update at the stage of early scientific momentum rather than a defined clinical milestone.